Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma | ||||
| Suez Canal University Medical Journal | ||||
| Article 7, Volume 27, Issue 1, January 2024, Page 65-72 PDF (569.73 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/scumj.2024.343084 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Dalia I. Mohamed* ; Amr A.M. Kamel; Mohamed K. E. Kherbetawy | ||||
| Department of Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt | ||||
| Abstract | ||||
| Background: SOX2 is a transcription factor involved in the self-renewal and pluripotency of embryonic stem cells (ESCs). It is involved in various cancer types and affects cancer cell physiology viainvolvement in complicated cell signaling and protein-protein interactions. im: Our work aimedto assess the expression patterns of SOX2 in prostatic adenocarcinoma in correlation with the histopathological findings to evaluate its role as a prognostic marker or possible therapeutic target. Materials and Methods: forty-eight specimens of prostatic adenocarcinoma were stained first H&E then immunohistochemically for SOX2 and scored by two histopathologists. Results: thirty-eight specimens showed positive nuclear expression of SOX2; with variable degrees. SOX2 expression showed a statistically significant association with different grade groups; with p-value = 0.025. There was no statistically significant association between its expression and the patient’s demographic data. Conclusion: Overexpression of SOX2 in Prostatic Adenocarcinoma could be an indicator of higher tumor grade and poor prognosis. It could be used as a prognostic biomarker for tumor aggressiveness. | ||||
| Keywords | ||||
| SOX2; transcription factor; immunohistochemistry; prostatic adenocarcinoma | ||||
|
Statistics Article View: 36 PDF Download: 49 |
||||
